410014 ~#Battelle Pacific Northwest P.o. BOX 999 Richland, September 20, 1982 R Telephone Telex \\’ashington Laboratories U.S.A. 99352 (5o9) 376-3043 15-2874 FTS: 444-3043 Dr. William L. Robinson University of California Lawrence Livermore Laboratory P.O. Box 808 Livermore, CA 94550 Dear Bill: I’ve reviewed the Marshall Islands Dosimetry Document you sent me, and find I note a nothing that prompts me to register any substantial objections. few minor comments below, primarily to prove that I did look at the document, and to maintain my reputation for always being able to find something to complain about. Page 1, last line: The phrase “ ...but do present a long-term source of exposure,’f should, in my opinion, be deleted, or explained in greater detai 1. It suggests that there really is a problem with transuranics, but doesn’t define this problem. I don’t think the subject is addressed anywhere else in the report, which is another reason for considering it inappropriate for the abstract. Page 14, lines 6-8: The gut transfer factors employed are those of ICRP You should be aware, and are probably the best to use in this document. however,